These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2311265)

  • 1. Defective oxidation of pristanic acid by fibroblasts from patients with disorders in propionic acid metabolism.
    Poulos A; Johnson D; Singh H
    Clin Genet; 1990 Feb; 37(2):106-10. PubMed ID: 2311265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the oxidation of phytanic acid and pristanic acid in human fibroblasts by acylcarnitine analysis.
    Verhoeven NM; Jakobs C; ten Brink HJ; Wanders RJ; Roe CR
    J Inherit Metab Dis; 1998 Oct; 21(7):753-60. PubMed ID: 9819705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of odd-numbered fatty acid oxidation to propionate production in neonates with methylmalonic and propionic acidaemias.
    Wendel U; Zass R; Leupold D
    Eur J Pediatr; 1993 Dec; 152(12):1021-3. PubMed ID: 8131803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylmalonic and propionic acidemias: lipid profiles of normal and affected human skin fibroblasts incubated with [1-14C]propionate.
    Giudici TA; Chen RG; Oizumi J; Shaw KN; Ng WG; Donnell GN
    Biochem Med Metab Biol; 1986 Jun; 35(3):384-98. PubMed ID: 2872907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stable isotope studies in propionic and methylmalonic acidaemia.
    Leonard JV
    Eur J Pediatr; 1997 Aug; 156 Suppl 1():S67-9. PubMed ID: 9266219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accumulation of odd-numbered long-chain fatty acids in fetuses and neonates with inherited disorders of propionate metabolism.
    Wendel U; Baumgartner R; van der Meer SB; Spaapen LJ
    Pediatr Res; 1991 Apr; 29(4 Pt 1):403-5. PubMed ID: 1852536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute neonatal nonketotic hyperglycinemia: normal propionate and methylmalonate metabolism.
    Baumgartner ER; Bachmann C; Brechbühler T; Wick H
    Pediatr Res; 1975 Jul; 9(7):559-64. PubMed ID: 240144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human metabolism of phytanic acid and pristanic acid.
    Verhoeven NM; Jakobs C
    Prog Lipid Res; 2001 Nov; 40(6):453-66. PubMed ID: 11591435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propionate metabolism in cultured human cells after overexpression of recombinant methylmalonyl CoA mutase: implications for somatic gene therapy.
    Wilkemeyer M; Stankovics J; Foy T; Ledley FD
    Somat Cell Mol Genet; 1992 Nov; 18(6):493-505. PubMed ID: 1363155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidation of pristanic acid in fibroblasts and its application to the diagnosis of peroxisomal beta-oxidation defects.
    Paton BC; Sharp PC; Crane DI; Poulos A
    J Clin Invest; 1996 Feb; 97(3):681-8. PubMed ID: 8609223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the degradation of [U-3H]-phytanic acid and [U-3H]-pristanic acid in cultured fibroblasts from children with peroxisomal disorders.
    Kase BF; Björkhem I
    Scand J Clin Lab Invest; 1996 May; 56(3):211-7. PubMed ID: 8761525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of propionate as a degradation product of phytanic acid oxidation in rat and human tissues.
    Hutton D; Steinberg D
    J Biol Chem; 1973 Oct; 248(19):6871-5. PubMed ID: 4745448
    [No Abstract]   [Full Text] [Related]  

  • 13. Secondary mitochondrial dysfunction in propionic aciduria: a pathogenic role for endogenous mitochondrial toxins.
    Schwab MA; Sauer SW; Okun JG; Nijtmans LG; Rodenburg RJ; van den Heuvel LP; Dröse S; Brandt U; Hoffmann GF; Ter Laak H; Kölker S; Smeitink JA
    Biochem J; 2006 Aug; 398(1):107-12. PubMed ID: 16686602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phytanic acid alpha-oxidation in peroxisomal disorders: studies in cultured human fibroblasts.
    Verhoeven NM; Schor DS; Roe CR; Wanders RJ; Jakobs C
    Biochim Biophys Acta; 1997 Oct; 1361(3):281-6. PubMed ID: 9375802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formic acid is a product of the alpha-oxidation of fatty acids by human skin fibroblasts: deficiency of formic acid production in peroxisome-deficient fibroblasts.
    Poulos A; Sharp P; Singh H; Johnson DW; Carey WF; Easton C
    Biochem J; 1993 Jun; 292 ( Pt 2)(Pt 2):457-61. PubMed ID: 8503880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic complementation in heterokaryons of human fibroblasts defective in cobalamin metabolism.
    Gravel RA; Mahoney MJ; Ruddle FH; Rosenberg LE
    Proc Natl Acad Sci U S A; 1975 Aug; 72(8):3181-5. PubMed ID: 1059104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propionic acidaemia: clinical, biochemical and therapeutic aspects. Experience in 30 patients.
    Lehnert W; Sperl W; Suormala T; Baumgartner ER
    Eur J Pediatr; 1994; 153(7 Suppl 1):S68-80. PubMed ID: 7957390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accumulation of pristanic acid (2, 6, 10, 14 tetramethylpentadecanoic acid) in the plasma of patients with generalised peroxisomal dysfunction.
    Poulos A; Sharp P; Fellenberg AJ; Johnson DW
    Eur J Pediatr; 1988 Feb; 147(2):143-7. PubMed ID: 2452737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phytanic acid and pristanic acid, branched-chain fatty acids associated with Refsum disease and other inherited peroxisomal disorders, mediate intracellular Ca2+ signaling through activation of free fatty acid receptor GPR40.
    Kruska N; Reiser G
    Neurobiol Dis; 2011 Aug; 43(2):465-72. PubMed ID: 21570468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased urinary metabolite excretion during fasting in disorders of propionate metabolism.
    Thompson GN; Chalmers RA
    Pediatr Res; 1990 Apr; 27(4 Pt 1):413-6. PubMed ID: 2342832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.